Bulk purchase order - tolvaptan (jynarque)
Ended Awarded Last action
- Contract number
- 36C26022F0016
- Awardee
-
Otsuka America Pharmaceutical Inc. UEI QKABLBMA8FT9
- Awarding agency
-
Veterans Integrated Service Network 20
Veterans Health Administration, Department of Veterans Affairs
- Obligated
- $203,334
Award facts
- Contract value 100% obligated
- $203,334.36 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- Contracting staff
- NAICS code
- 325412 Pharmaceutical Preparation Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 1 offer Multiple Award, Fair Opportunity
- Pricing
- Firm Fixed Price
- Place of performance
- Rockville, MD 20850, USA
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Close Out | -$36 | |
| Supplemental Agreement for work within scope | $56,937 | |
| Supplemental Agreement for work within scope | $11,557 | |
| Original award | $134,876 |
About this award
This is a closeout delivery order modification issued by the Department of Veterans Affairs Veterans Integrated Service Network 20 (VISN 20) to Otsuka America Pharmaceutical Inc. for a bulk purchase of Tolvaptan (Jynarque), a specialized pharmaceutical treatment for autosomal dominant polycystic kidney disease and hyponatremia. The contract, awarded on October 1, 2021, with a firm fixed price and ceiling value of $203,334.36, was completed by September 30, 2022. The delivery order was placed under the Pharmaceuticals and Drugs Federal Supply Schedule (FSS-61-IB) and did not utilize a set-aside designation. Performance was fulfilled in Potomac, Maryland.
This delivery order represents a routine procurement under Otsuka America Pharmaceutical Inc.'s substantial Indefinite Delivery Vehicle arrangements with the VA, including an $83.3 million Blanket Purchase Agreement for Jynarque with the National Acquisition Center and a $396 million Federal Supply Schedule contract for pharmaceutical and hematology products. As a for-profit pharmaceutical manufacturer headquartered in Rockville, Maryland, Otsuka America has established itself as a primary supplier of specialty pharmaceuticals to the VA's Veterans Health Administration across multiple integrated service networks, enabling the organization to efficiently deliver critical medication treatments to veterans nationwide.
Quick answers
Who was awarded contract 36C26022F0016?
36C26022F0016 was awarded to Otsuka America Pharmaceutical Inc. by Veterans Integrated Service Network 20 (Veterans Health Administration) on October 1, 2021.
How much is contract 36C26022F0016 worth?
The government has obligated $203,334 on 36C26022F0016.
Is contract 36C26022F0016 an order under another contract?
Yes. 36C26022F0016 is a delivery order under 36F79720D0099, a federal supply schedule, on Pharmaceuticals and Drugs (FSS-61-IB).
Was contract 36C26022F0016 competed?
The extent of competition for 36C26022F0016 was full and open competition. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award